Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALISON ALLEN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1285780874
CMS profile
194113
Location
BASALT, CO

General Payments · PY2018–2024

$8,683.51

  • Reported across 305 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,011.93

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,011.93 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Celgene Corporation $129.67 4
EMD Serono, Inc. $117.99 2
ARGENX US, INC. $109.52 4
Lilly USA, LLC $103.29 4
TG THERAPEUTICS, INC. $94.83 3
NOVARTIS PHARMACEUTICALS CORPORATION $88.90 3
ABBVIE INC. $81.24 4
EISAI INC. $68.26 3
Amgen Inc. $48.89 2
SK Life Science, Inc. $30.34 1
Janssen Scientific Affairs, LLC $29.37 1
Lundbeck LLC $28.00 1
UCB, Inc. $27.96 1
PFIZER INC. $27.67 1
Alexion Pharmaceuticals, Inc. $26.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,023.35 35
PY2019 $3,315.51 79
PY2020 $491.31 25
PY2021 $1,061.14 50
PY2022 $907.70 44
PY2023 $872.57 37
PY2024 $1,011.93 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.55 01/23/2024 Food and Beverage Undisputed 01/23/2026 1103206921 CMS
ABBVIE INC. $17.66 05/18/2024 Food and Beverage Undisputed 01/23/2026 1103206923 CMS
ABBVIE INC. $22.78 07/22/2024 Food and Beverage Undisputed 01/23/2026 1103206925 CMS
ABBVIE INC. $19.25 09/20/2024 Food and Beverage Undisputed 01/23/2026 1103206927 CMS
Alexion Pharmaceuticals, Inc. $26.00 09/27/2024 Food and Beverage Undisputed 01/23/2026 1094028491 CMS
Amgen Inc. $23.34 03/01/2024 Food and Beverage Undisputed 01/23/2026 1111514495 CMS
Amgen Inc. $25.55 06/27/2024 Food and Beverage Undisputed 01/23/2026 1111514497 CMS
ARGENX US, INC. $23.96 01/19/2024 Food and Beverage Undisputed 01/23/2026 1142112115 CMS
ARGENX US, INC. $29.86 04/05/2024 Food and Beverage Undisputed 01/23/2026 1142104691 CMS
ARGENX US, INC. $26.08 09/16/2024 Food and Beverage Undisputed 01/23/2026 1142102274 CMS
ARGENX US, INC. $29.62 11/18/2024 Food and Beverage Undisputed 01/23/2026 1142119963 CMS
Celgene Corporation $40.07 04/30/2024 Food and Beverage Undisputed 01/23/2026 1101099002 CMS
Celgene Corporation $37.19 08/23/2024 Food and Beverage Undisputed 01/23/2026 1101099012 CMS
Celgene Corporation $34.83 11/04/2024 Food and Beverage Undisputed 01/23/2026 1101099022 CMS
Celgene Corporation $17.58 12/04/2024 Food and Beverage Undisputed 01/23/2026 1101099024 CMS
Eisai Inc. $20.72 02/13/2024 Food and Beverage Undisputed 01/23/2026 1110728055 CMS
Eisai Inc. $24.21 05/09/2024 Food and Beverage Undisputed 01/23/2026 1110728057 CMS
Eisai Inc. $23.33 12/03/2024 Food and Beverage Undisputed 01/23/2026 1110728059 CMS
EMD Serono, Inc. $45.18 02/29/2024 Food and Beverage Undisputed 01/23/2026 1120244999 CMS
EMD Serono, Inc. $72.81 05/03/2024 Food and Beverage Undisputed 01/23/2026 1120245805 CMS
Janssen Scientific Affairs, LLC $29.37 08/30/2024 Food and Beverage Undisputed 01/23/2026 1078846241 CMS
Lilly USA, LLC $28.71 04/25/2024 Food and Beverage Undisputed 01/23/2026 1136021944 CMS
Lilly USA, LLC $24.04 06/21/2024 Food and Beverage Undisputed 01/23/2026 1136023712 CMS
Lilly USA, LLC $25.06 07/11/2024 Food and Beverage Undisputed 01/23/2026 1136028609 CMS
Lilly USA, LLC $25.48 11/15/2024 Food and Beverage Undisputed 01/23/2026 1136023831 CMS
Lundbeck LLC $28.00 03/08/2024 Food and Beverage Undisputed 01/23/2026 1145890725 CMS
Novartis Pharmaceuticals Corporation $30.50 04/16/2024 Food and Beverage Undisputed 01/23/2026 1086617933 CMS
Novartis Pharmaceuticals Corporation $24.75 08/09/2024 Food and Beverage Undisputed 01/23/2026 1086617935 CMS
Novartis Pharmaceuticals Corporation $33.65 11/12/2024 Food and Beverage Undisputed 01/23/2026 1086617937 CMS
PFIZER INC. $27.67 10/04/2024 Food and Beverage Undisputed 01/23/2026 1132126992 CMS
SK Life Science, Inc. $30.34 04/23/2024 Food and Beverage Undisputed 01/23/2026 1154129497 CMS
TG Therapeutics, Inc. $40.00 02/12/2024 Food and Beverage Undisputed 01/23/2026 1136873033 CMS
TG Therapeutics, Inc. $33.52 10/24/2024 Food and Beverage Undisputed 01/23/2026 1136873029 CMS
TG Therapeutics, Inc. $21.31 11/21/2024 Food and Beverage Undisputed 01/23/2026 1136873035 CMS
UCB, Inc. $27.96 11/11/2024 Food and Beverage Undisputed 01/23/2026 1143051345 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.